The neuropsychiatry of multiple sclerosis

被引:146
作者
Feinstein, A [1 ]
机构
[1] Univ Toronto, Dept Psychiat, Toronto, ON M4N 3M5, Canada
来源
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE | 2004年 / 49卷 / 03期
关键词
multiple sclerosis; mood; cognition; neuroimaging; translational research; treatment;
D O I
10.1177/070674370404900302
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
This review describes the many neuropsychiatric abnormalities associated with multiple sclerosis (MS). These may be broadly divided into 2 categories: disorders of mood, affect, and behaviour and abnormalities affecting cognition. With respect to the former, the epidemiology, phenomenology, and theories of etiology are described for the syndromes of depression, bipolar disorder, euphoria, pathological laughing and crying, and psychosis attributable to MS. The section discussing cognition reviews the prevalence and nature of cognitive dysfunction, with an emphasis on abnormalities affecting multiple domains of memory, speed of information processing, and executive function. The detection, natural history, and cerebral correlates of cognitive dysfunction are also discussed. Finally, treatment pertaining to all these disorders is reviewed, with the observation that translational research has been found wanting when it comes to providing algorithms to guide clinicians. Guidelines derived from general psychiatry still largely apply, although they may not always be most effective in patients with neurologic disorders. The importance of future research addressing this imbalance is emphasized, for neuropsychiatric sequelae add significantly to the morbidity associated with MS.
引用
收藏
页码:157 / 163
页数:7
相关论文
共 50 条
  • [41] Gut microbiome in multiple sclerosis-related cognitive impairment
    Ghadiri, Fereshteh
    Ebadi, Zahra
    Asadollahzadeh, Elnaz
    Moghadasi, Abdorreza Naser
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 67
  • [42] Quality of Life, Cognition and Mood in Adults with Pediatric Multiple Sclerosis
    Krysko, Kristen M.
    O'Connor, Paul
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2016, 43 (03) : 368 - 374
  • [43] Cognition, mood and fatigue in patients in the early stage of multiple sclerosis
    Simioni, S.
    Ruffieux, C.
    Bruggimann, L.
    Annoni, F.-M.
    Schluep, Myriam
    SWISS MEDICAL WEEKLY, 2007, 137 (35-36) : 496 - 501
  • [44] Neurodegeneration and neuroprotection in multiple sclerosis
    Davydovskaya, M. V.
    Boyko, A. N.
    Gusev, E. I.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2009, 109 (07) : 44 - 52
  • [45] The Gut Microbiome in Multiple Sclerosis
    Daniel W. Mielcarz
    Lloyd H. Kasper
    Current Treatment Options in Neurology, 2015, 17
  • [46] Remyelinating strategies in multiple sclerosis
    Luessi, Felix
    Kuhlmann, Tanja
    Zipp, Frauke
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (11) : 1315 - 1334
  • [47] Diagnosis and treatment of multiple sclerosis
    Zavalishin, I. A.
    Peresedova, A. V.
    Stoida, N. I.
    Gur'yanova, O. E.
    Arzumanyan, N. Sh
    Alekseeva, N. S.
    Eliseeva, D. D.
    Gulevskaya, T. S.
    Bryukhov, V. V.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2011, 111 (06) : 89 - 96
  • [48] Treatment of symptoms in multiple sclerosis
    Schwendimann, RN
    NEUROLOGICAL RESEARCH, 2006, 28 (03) : 306 - 315
  • [49] Treatment of Pediatric Multiple Sclerosis
    Narula, Sona
    Hopkins, Sarah E.
    Banwell, Brenda
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2015, 17 (03) : 1 - 12
  • [50] Cognitive phenotypes in multiple sclerosis
    Leavitt, Victoria M.
    Tosto, Gabriella
    Riley, Claire S.
    JOURNAL OF NEUROLOGY, 2018, 265 (03) : 562 - 566